三维魔方源代码.doc

第三届国际中医、中西医结合肿瘤学术交流大会暨第十二届全国中西医结合肿瘤学术大会三维适形放疗联合中药紫龙金治疗老年中晚期NScLC 临床观察李维廉王风玮朱思伟王辉姚嫱秦玉坤摘要目的:观察三维适形放疗(3D-CRT)联合中药紫金龙治疗70岁以上老年中晚期非小细胞肺癌(NSCLC)的疗效和耐受性。方法:37例中晚期NSCLC随机分为治疗组19?哉兆椋保咐阶榫邮埽常模茫遥?2GY/F每日1次,每周5次至DT 60—64GY。,对照组单接受放疗。结果:%%(P=);l、2年病灶局部控制率(DCR)%,% (P<=%,%(P=),主要毒副反应为骨髓抑制、消化道反应以及放射性食管炎、放射性肺炎,QOL治疗组优于对照组。结论:3D-CRT联合中药紫龙金治疗70岁以上晚期NSCLC能明显提高患者一年疾病局部控制率,改善KPS,增加体重,不良反应较轻,老年患者易于接受。关键词老年非小细胞肺癌三维适形放射治疗中药紫龙金 To Evaluate the Efficacy and Toxicities of 3D—bined with TCM—Zilongjin Elderly NSCLC Patients LI Weilian,WANG Fengwei,ZHU siwei,WANG Hui,YAO Qiang,Q矾Yukun Abstract Objective:To evaluate the efficacy and toxicities of three—dimensionalradiotherapy(3D—bine with TCM Zilongjin stage HI—IV :Atotal of thirty seven elderly(>70year old)patients with advanced NSCLC were randomly assigned Group 19 patients and controlto the treatment 18 groups were received group3D—CRT with a total dose of 60—64Gy,,once a daily,5times per in thetreatment group were treated with bined TCM-Zilongjin 4 until the and two years disease control rate(DCR),quality of life(QOL)and peripheral blood wereexamined after :No significant difference were found in RR between thetreatment group and control group(p=),one and t